REGENERON PHARMACEUTICALS, INC.
Ticker: 872589
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 3.6K-4.0% | 3.8K+2.1% | 3.7K+21.4% | 3.0K-18.6% | 3.7K+4.9% | 3.5K+12.8% | 3.1K-6.5% | 3.4K |
| Total Income | 3.6K-4.0% | 3.8K+2.1% | 3.7K+21.4% | 3.0K-18.6% | 3.7K+4.9% | 3.5K+12.8% | 3.1K-6.5% | 3.4K |
| EXPENSES | ||||||||
| Expenditure | 3.0K+8.6% | 2.7K+5.1% | 2.6K+6.5% | 2.4K-4.1% | 2.5K+2.6% | 2.5K+3.5% | 2.4K+6.3% | 2.3K |
| Tax | 104.00-65.7% | 303.30+138.6% | 127.10+32.0% | 96.30-36.8% | 152.40-22.2% | 195.80+1019.2% | -21.30-120.7% | 103.00 |
| PROFIT | ||||||||
| PBT | 831.20-52.9% | 1.8K+16.1% | 1.5K+67.8% | 905.00-39.4% | 1.5K-8.3% | 1.6K+132.4% | 700.70-36.9% | 1.1K |
| Net Profit | 727.20-50.2% | 1.5K+4.9% | 1.4K+72.1% | 808.70-39.7% | 1.3K-6.4% | 1.4K+98.4% | 722.00-28.4% | 1.0K |
| KEY METRICS | ||||||||
| OPM % | 17.83%-9.52pp | 27.35%-2.02pp | 29.37%+9.83pp | 19.54%-12.16pp | 31.70%+1.55pp | 30.15%+6.26pp | 23.89%-9.15pp | 33.04% |
| NPM % | 20.17%-18.72pp | 38.89%+1.03pp | 37.86%+11.16pp | 26.70%-9.33pp | 36.03%-4.35pp | 40.38%+17.42pp | 22.96%-7.01pp | 29.97% |
| EPS | 6.99-50.4% | 14.09+6.4% | 13.24+74.7% | 7.58-38.9% | 12.40-6.4% | 13.25+97.8% | 6.70-29.3% | 9.48 |
Corporate Events
Board MeetingREGN
202612Jun
Board Meeting
Shareholders voted on the election of five Class II director…
SEC Filing ↗